Blog — Page 62

Bank Statement Loan Guide 2026: Self-Employed and Freelancer Mortgage Without W-2s

Bank Statement Loan Guide 2026: Self-Employed and Freelancer Mortgage Without W-2s

A practical US guide to bank statement loans, the non-QM mortgage that lets self-employed, freelance, gig, and business-owner borrowers qualify on 12 to 24 months of deposits instead of tax returns. Covers deposit averaging, the expense factor, rates and down payment, reserves, requirements, how it compares to DSCR and P&L loans, and a refinance-later plan.

bank statement loan self-employed mortgage non-QM loan
Commercial Crime Insurance 2026: Employee Theft, Wire Fraud, and Social Engineering Explained

Commercial Crime Insurance 2026: Employee Theft, Wire Fraud, and Social Engineering Explained

A practical US-market guide to commercial crime insurance and fidelity coverage. Learn what it protects against, the core insuring agreements (employee dishonesty, forgery, funds transfer fraud, computer fraud, social engineering), how premiums are priced, how it differs from a fidelity bond and cyber insurance, and the coverage gaps that catch businesses off guard.

commercial crime insurance employee dishonesty wire fraud
Selvas AI (108860) Stock Outlook 2026: A 20-Year Korean Voice and Document AI Engine Meets Theme-Stock Volatility

Selvas AI (108860) Stock Outlook 2026: A 20-Year Korean Voice and Document AI Engine Meets Theme-Stock Volatility

Selvas AI (KOSDAQ 108860) 2026 stock analysis: two decades of Korean speech recognition (STT/TTS), handwriting and document OCR engines, on-device AI, the Selvas Healthcare link, generative-AI theme volatility, competition from Big Tech foundation models, valuation versus modest profit, governance risk, and how foreign investors access this Korea-listed AI small cap.

Selvas AI 108860 speech recognition
Viol (335890) Stock Outlook 2026: Sylfirm X, Disposable Tips, and the Razor-Blade Engine

Viol (335890) Stock Outlook 2026: Sylfirm X, Disposable Tips, and the Razor-Blade Engine

Viol (KOSDAQ 335890) 2026 stock outlook. A deep qualitative analysis of the Sylfirm X RF microneedling platform, the razor-blade model where devices seed recurring high-margin needle-tip sales, distributor-led expansion across the US, Europe, and the Middle East, competition from Classys, Wontech, Lutronic, and InMode, and the aesthetic-capex cycle risk that defines this Korean medtech name.

335890 Viol Sylfirm X